☰

Paul Dent

Affiliations: 
Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Biochemistry, Cell Biology
Google:
"Paul Dent"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Clint Mitchell grad student 2006 VCU
Aditi P. Martin grad student 2009 VCU
Teneille D. Walker grad student 2009 VCU
Mary D. Bareford grad student 2012 VCU
Hossein A. Hamed grad student 2012 VCU

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Booth MR, Booth L, Roberts JL, et al. (2024) GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells. Oncotarget. 15: 124-133
Booth L, Roberts JL, Poklepovic A, et al. (2023) Autophagy as a therapeutic mechanism to kill drug-resistant cancer cells. Anti-Cancer Drugs
Booth L, Poklepovic A, Hancock JF, et al. (2023) Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells. Anti-Cancer Drugs. 34: 1025-1034
Bordeaux ZA, Kwatra SG, Booth L, et al. (2023) A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations. Anti-Cancer Drugs. 34: 544-550
Booth L, Roberts JL, West C, et al. (2022) GZ17-6.02 kills prostate cancer cells and . Frontiers in Oncology. 12: 1045459
Booth L, West C, Moore RP, et al. (2022) GZ17-6.02 and axitinib interact to kill renal carcinoma cells. Oncotarget. 13: 281-290
Booth L, West C, Moore RP, et al. (2022) GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells. Oncotarget. 13: 92-104
Roberts JL, Booth L, Poklepovic A, et al. (2021) Axitinib and HDAC Inhibitors Interact to Kill Sarcoma Cells. Frontiers in Oncology. 11: 723966
Booth L, West C, Moore RP, et al. (2021) GZ17-6.02 and Pemetrexed Interact to Kill Osimertinib-Resistant NSCLC Cells That Express Mutant ERBB1 Proteins. Frontiers in Oncology. 11: 711043
Dent P, Booth L, Poklepovic A, et al. (2021) Neratinib kills B-RAF V600E melanoma via ROS-dependent autophagosome formation and death receptor signaling. Pigment Cell & Melanoma Research
See more...